Viewing nowCombinationAbajet Tablet 10/10 mg
Atorvastatin Calcium Trihydrate 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.

MFDS item code 202101394 · Approved 2021.02.18 · Insurance code 660703510
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medication helps lower serum total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels in patients suffering from primary hypercholesterolemia, including familial or non-familial hypercholesterolemia and mixed dyslipidemia, while increasing HDL cholesterol levels. It is particularly used as an adjunctive therapy in patients with homozygous familial hypercholesterolemia or when other treatments are ineffective. Although the drug is expected to reduce the risk of cardiovascular disease, a thorough diagnosis and adherence to dietary therapy prior to use are crucial. Additionally, other secondary causes such as diabetes and hypothyroidism must be confirmed and managed, and lipid levels should be regularly monitored. This medication is utilized to control serum lipid levels and improve cardiovascular risk.
Administer this medication once daily, regardless of meals. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medication. The dose of this medication should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of this medication is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients who require a greater reduction in LDL cholesterol (55% or more), the recommended initial dose is 10/40mg once daily. After starting this medication or adjusting the dose, check serum lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. Administer this medication as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful.
This medication has reported rare side effects such as rhabdomyolysis, which can lead to serious muscle issues. Patients with conditions that may pose a high risk for serious muscle problems, such as acute infections, hypotension, major surgery, trauma, metabolic or electrolyte disturbances, or uncontrolled seizures, may need to temporarily cease or discontinue taking this medication. Patients with allergies to any components of this drug, those with active liver disease or persistent unexplained liver enzyme elevation, patients with muscle disorders, pregnant or potentially pregnant women, nursing mothers, patients taking certain antiviral medications, and those with genetic issues such as lactose intolerance should not take this drug. Individuals with a history of alcohol abuse, liver disease, poor kidney function, hypothyroidism, family history of muscle disorders, the elderly, and patients on specific medications should take this drug cautiously and be closely monitored for muscle pain or drug-related side effects. If symptoms such as muscle pain, weakness, fatigue, or fever appear during treatment, the physician should be informed immediately and necessary tests should be conducted. Since liver function abnormalities may occur, liver function testing should be conducted before and during therapy, and if signs of liver damage appear, the medication should be discontinued. This drug is not to be administered to pregnant or breastfeeding women, and women of childbearing potential should use appropriate contraceptive methods during treatment. Its safety in pediatric patients has not been established and is therefore not recommended. In case of overdose, since there is no specific antidote, management should be symptomatic and should include liver function and muscle enzyme tests. This drug may interact with several medications; hence, patients taking other medications must consult a physician or pharmacist, particularly regarding drugs affecting liver metabolism. Caution is advised regarding dizziness when driving or operating machinery. Regular medical exams and necessary tests during treatment are critical, and any unusual symptoms should be reported immediately.
Acute renal failure due to myoglobinuria, rhabdomyolysis, myalgia, abdominal pain, elevation of liver enzymes, increased ALT, increased AST, musculoskeletal pain, dizziness, cough, nausea, arthralgia, muscle weakness, hyperkalemia, bronchitis, sinusitis, flushing, intracranial aneurysm, restless legs syndrome, depression, bronchiolitis, dental abscess, vestibular neuritis, bradycardia, hypotension, anemia, hernia, vitamin D deficiency, gastric polyp, duodenal polyp, duodenitis, jaundice, erectile dysfunction, breast lump, skin lump, ingrown toenail, thyroid adenoma, weakness, fatigue, chest pain, peripheral edema, fatigue, fever, rhinitis, hyperglycemia, hypoglycemia, weight gain, loss of appetite, constipation, abdominal bloating, dyspepsia, diarrhea, vomiting, belching, pancreatitis, pharyngeal and laryngeal pain, nosebleed, insomnia, nightmares, headache, paresthesia, sensory reduction, dysgeusia, amnesia, peripheral neuropathy, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, complications due to rupture, myopathy, myositis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, allergic reactions, anaphylaxis, hepatitis, cholestasis, liver failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, angioedema, erythema multiforme, mucous membrane syndrome, toxic epidermal necrolysis, gynecomastia, increased creatine kinase levels in blood, positive urinary leukocytes, nightmares, vomiting, abdominal abnormalities, hepatitis, cholelithiasis, cholecystitis, drug-induced liver injury, eosinophilia, drug reactions with systemic symptoms, severe cutaneous adverse reactions, fatigue, chest discomfort, edema, asthenia, generalized edema, diabetic neuropathy, tremors, epigastric pain, gastritis, dry mouth, epigastric discomfort, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, sputum, renal failure, liver dysfunction, elevated serum creatinine, increased blood pressure, elevated blood urea, increased CPK, abnormal liver function tests
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to protect it from air and moisture, and it is best kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the drug’s effectiveness for a longer period.
A film-coated tablet in a capsule shape, convex on both sides, consisting of white or pale yellow.
30 tablets/box [10 tablets/Alu-Alu x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAtorvastatin Calcium Trihydrate 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Withus Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.